GTR Home > Tests > Search results - C1858079[DISCUI]

Apply filters

Showing tests for all 1355 conditions

Compare labs

Your search term can be found in tests with a total of 1355 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1858079[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 27 tests for 1355 conditions in 7 labs

CCOL2A1 Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)

CCOL2A1 Deletion/Duplication Analysis

Test targets
Methods
  • D Deletion/duplication analysis
Total conditions (10)

CStickler Syndrome NextGene Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (6)

CMultiple Epiphyseal Dysplasia NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (25)
Total targets (7)

COsteoarthritis with mild chondrodysplasia via the COL2A1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCOL2A1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (14)

CSkeletal Dysplasias NGS panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (371)
Total targets (161)

CMultiple Epiphyseal Dysplasia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (30)
Total targets (7)

CCOL2A1

Lab: Laboratoire des maladies rares et Auto-Inflammatoires CHRU Montpellier Montpellier, Languedoc-Roussillon, France
Test targets
Methods
  • S Mutation scanning of the entire coding region
Total conditions (11)

CSkeletal Dysplasia: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (365)
Total targets (163)

CDisproportionate Short Stature: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (200)
Total targets (77)

CConnective Tissue Disorders: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (65)
Total targets (29)

CMultiple Epiphyseal Dysplasia: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (7)

CVitreoretinopathy: Sequencing and Deletion/Duplication Panel

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (33)
Total targets (9)

CStickler Syndrome: Sequencing Panel

Methods
  • C Sequence analysis of the entire coding region
Total conditions (26)
Total targets (5)

CEye Disorders: Comprehensive Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (317)
Total targets (203)

Showing 1 to 20 of 27 tests for 1355 conditions in 7 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk